Your search for ‘Smart & Biggar’ returned 2,497 results

On January 6, 2021, the Federal Court issued its decision in two patent infringement actions pursuant to subsection 6(1) of the Patented Medicines

The case involving a Children's Hospital of Eastern Ontario ("CHEO") challenge to an isolated gene patent has settled.

On September 21, 2020, the High Court of England and Wales dismissed an appeal and upheld the decision of the UK Intellectual Property Office (UKIPO) that a machine cannot be regarded as an inventor under the UK Patents Act 1977.

MPHJ Tech v. Ricoh is a 2017 decision of the U.S. Federal circuit, which should caution patent applicants and agents that differences between a provisional and regular filing can have profound effects...

The Federal Court of Appeal has dismissed Lilly's appeals of judgments that held Canadian Patent No. 2,371,684 claims invalid.

The United States Supreme Court (SCOTUS) recently issued a landmark copyright decision in Google LLC v Oracle America, Inc. finding that Google was not liable for copyright infringement...

The Federal Court, in its recent decision Sunovion Pharmaceuticals Canada Inc. v. Taro Pharmaceuticals Inc. (2021 FC 37)

On October 27, 2020, the Patented Medicine Prices Review Board released the National Drug Prescription Utilization System's analytic study of the Canadian oncology market for 2010 to 2019.

2017 will mark the 150th anniversary of Canadian confederation. The government of Canada has already started the countdown, and many businesses are preparing to join in the celebrations.

A Bill, short-titled the "Digital Privacy Act", was introduced in the Senate on April 8, 2014.

There has been a significant amount of uncertainty in Canada regarding the patentability of use claims which include dosages and dosage regimens.

Occasionally, results of litigation seems so surprising that you wonder if there has to be more to the case than what the decision discloses

This spring, the Supreme Court of Canada (SCC) will consider the scope of patentable subject-matter as it relates to "methods of medical treatment".

‎Licensing-out is not just for low-tech consumer products, it can also be used to commercialize cutting edge science.

A cautionary tale from south of the border.

The United States Patent and Trademark Office (USPTO) announced another new initiative relating to COVID-19 to help encourage innovation for products and processes related to COVID-19.

On November 9, 2016, the Canadian Trademarks Office issued a Practice Notice to clarify its position with respect to trademarks that are geographic names.

Although pharmaceutical counterfeiting has not, historically, been a problem of significant magnitude in Canada, with counterfeit health products on the rise globally, fraudulent drugs are increasingly showing up...